SE8801514L - Farmaceutisk komposition - Google Patents

Farmaceutisk komposition

Info

Publication number
SE8801514L
SE8801514L SE8801514A SE8801514A SE8801514L SE 8801514 L SE8801514 L SE 8801514L SE 8801514 A SE8801514 A SE 8801514A SE 8801514 A SE8801514 A SE 8801514A SE 8801514 L SE8801514 L SE 8801514L
Authority
SE
Sweden
Prior art keywords
useful
deseases
agent
pharmaceutical composition
animal
Prior art date
Application number
SE8801514A
Other languages
English (en)
Other versions
SE8801514D0 (sv
SE502923C2 (sv
Inventor
M Yamamoto
S Araki
H Yamamoto
I Yamatsu
T Suzuki
A Kajiwara
Y Suzuki
H Arai
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP57089806A external-priority patent/JPS58206517A/ja
Priority claimed from JP10620382A external-priority patent/JPS58225014A/ja
Priority claimed from JP18364382A external-priority patent/JPS5973533A/ja
Priority claimed from JP18364282A external-priority patent/JPS5973513A/ja
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of SE8801514L publication Critical patent/SE8801514L/sv
Publication of SE8801514D0 publication Critical patent/SE8801514D0/sv
Publication of SE502923C2 publication Critical patent/SE502923C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/02—Acyclic alcohols with carbon-to-carbon double bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/15—Unsaturated ethers containing only non-aromatic carbon-to-carbon double bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/04—Saturated compounds containing keto groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/203—Unsaturated compounds containing keto groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/08—Preparation of carboxylic acids or their salts, halides or anhydrides from nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/377—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • C07C51/38—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups by decarboxylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/007—Esters of unsaturated alcohols having the esterified hydroxy group bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12—Acetic acid esters
    • C07C69/14—Acetic acid esters of monohydroxylic compounds
    • C07C69/145—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/78—Benzoic acid esters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
    • C12C11/00—Fermentation processes for beer
    • C12C11/02—Pitching yeast

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8801514A 1982-05-28 1988-04-22 Användning av en polyprenylförening för framställning av protylaktiskt/terapeutiskt medel för humana och animala sjukdomar beroende på bristfälligt immunförsvar SE502923C2 (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP57089806A JPS58206517A (ja) 1982-05-28 1982-05-28 免疫機能不全による疾患の予防・治療剤
JP10620382A JPS58225014A (ja) 1982-06-22 1982-06-22 免疫機能不全による疾患の予防・治療剤
JP18364382A JPS5973533A (ja) 1982-10-21 1982-10-21 β，γ−ジヒドロポリプレニルアルコ−ル誘導体
JP18364282A JPS5973513A (ja) 1982-10-21 1982-10-21 免疫機能不全による疾患の予防・治療剤

Publications (3)

Publication Number Publication Date
SE8801514L true SE8801514L (sv) 1988-04-22
SE8801514D0 SE8801514D0 (sv) 1988-04-22
SE502923C2 SE502923C2 (sv) 1996-02-19

Family

ID=27467677

Family Applications (4)

Application Number Title Priority Date Filing Date
SE8303013A SE461650B (sv) 1982-05-28 1983-05-27 B -dihydropolyprenylalkoholderivat och farmaceutisk komposition innehaallande detsamma
SE8801513A SE502922C2 (sv) 1982-05-28 1988-04-22 Användning av en polyprenylförening för framställning av profylaktiskt/terapeutiskt medel för humana och animala sjukdomar beroende på bristfälligt immunförsvar
SE8801514A SE502923C2 (sv) 1982-05-28 1988-04-22 Användning av en polyprenylförening för framställning av protylaktiskt/terapeutiskt medel för humana och animala sjukdomar beroende på bristfälligt immunförsvar
SE8801515A SE502924C2 (sv) 1982-05-28 1988-04-22 Farmaceutisk komposition innehållande en verksam mängd av 3,7,11,15-tetrametyl-hexadeka-1-en-3-ol eller 3,7,11,15- tetrametyl-1,6,10,14-hexadekatetraen-3-ol

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SE8303013A SE461650B (sv) 1982-05-28 1983-05-27 B -dihydropolyprenylalkoholderivat och farmaceutisk komposition innehaallande detsamma
SE8801513A SE502922C2 (sv) 1982-05-28 1988-04-22 Användning av en polyprenylförening för framställning av profylaktiskt/terapeutiskt medel för humana och animala sjukdomar beroende på bristfälligt immunförsvar

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8801515A SE502924C2 (sv) 1982-05-28 1988-04-22 Farmaceutisk komposition innehållande en verksam mängd av 3,7,11,15-tetrametyl-hexadeka-1-en-3-ol eller 3,7,11,15- tetrametyl-1,6,10,14-hexadekatetraen-3-ol

Country Status (12)

Country Link
US (3) US4624966A (sv)
AT (1) AT389871B (sv)
CA (1) CA1310660C (sv)
CH (1) CH654823A5 (sv)
DE (2) DE3348500C2 (sv)
DK (1) DK171640B1 (sv)
ES (3) ES522789A0 (sv)
FR (5) FR2527597B1 (sv)
GB (7) GB2122610B (sv)
IT (1) IT1164256B (sv)
NL (1) NL194300C (sv)
SE (4) SE461650B (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3348500C2 (de) * 1982-05-28 1998-10-22 Eisai Co Ltd beta,gamma-Dihydropolyprenylalkoholderivat
JPS6112622A (ja) * 1984-06-29 1986-01-21 Kuraray Co Ltd 造血幹細胞の分化増殖促進剤
JPH0759504B2 (ja) * 1986-01-23 1995-06-28 エーザイ株式会社 ポリプレニルアルコ−ル含有注射剤
US5070107A (en) * 1989-04-28 1991-12-03 Lidak Pharmaceuticals Systemic antiviral treatment
US5071879A (en) * 1989-04-28 1991-12-10 Lidak Pharmaceuticals Systemic antiviral treatment
JP3166991B2 (ja) * 1992-08-17 2001-05-14 日清製粉株式会社 （ｓ）−２，３−ジヒドロポリプレノール化合物を有効成分とする癌増殖抑制および／または癌転移抑制剤
US5602184A (en) * 1993-03-03 1997-02-11 The United States Of America As Represented By Department Of Health And Human Services Monoterpenes, sesquiterpenes and diterpenes as cancer therapy
ATE383848T1 (de) * 1993-12-13 2008-02-15 Avanir Pharmaceuticals Formulierungen aus n-docosanol und saccharoseestern
TW338042B (en) * 1995-10-31 1998-08-11 Clary Kk Process for producing all trans-form polyprenols
GB2310138A (en) * 1996-02-19 1997-08-20 Juris Rubens Immunomodulating plant polyprenols
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5952392A (en) * 1996-09-17 1999-09-14 Avanir Pharmaceuticals Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
NZ336249A (en) * 1996-12-12 2000-11-24 Upjohn Co parenteral composition of a dihydropolyprenol and a pharmaceutically acceptable oil
CA2234326C (en) * 1997-04-25 2001-07-31 Yoshin Tamai Process for preparing polyprenols
US6784207B2 (en) * 2000-08-04 2004-08-31 Roche Vitamins Inc. Phytanic acid derivative compositions
CA2421026C (en) * 2001-10-16 2005-02-15 Avanir Pharmaceuticals Viral inhibition by n-docosanol
US7015022B2 (en) * 2002-06-07 2006-03-21 University Of Medicine & Dentistry Of New Jersey Mammalian catalase-dependent oxidation processes and methods for stimulating oxidative activities
US20050158329A1 (en) * 2004-01-21 2005-07-21 Ghosh Swapan K. Novel phytol derived immunoadjuvants and their use in vaccine formulations
US11110043B2 (en) 2015-11-16 2021-09-07 Wwu Alkenone-based formulations for topical applications

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4055M (sv) * 1964-01-20 1966-04-04
GB1459233A (en) 1973-08-29 1976-12-22 Inst Rech Chim Biolog Medicament containing a higher alkanol
US4059641A (en) * 1975-11-18 1977-11-22 Sankyo Company Limited Polyprenyl derivatives
JPS5391137A (en) * 1977-01-19 1978-08-10 Sumitomo Chem Co Ltd Stabilization of agrichemicals
JPS53145922A (en) * 1977-05-26 1978-12-19 Eisai Co Ltd Remedy for peptic ulcer containing prenyl ketone compound
US4199587A (en) * 1977-08-10 1980-04-22 Eisai Co., Ltd. Method of treating hypertension with polyprenyl alcohol ester
GB2002231B (en) * 1977-08-10 1982-03-17 Eisai Co Ltd Hypertension treating agent
JPS6058209B2 (ja) * 1978-12-01 1985-12-19 エーザイ株式会社 β，γ−ジヒドロポリプレニルアルコ−ルおよびそれからなる血圧降下剤
FR2443245A1 (fr) * 1978-12-07 1980-07-04 Nisshin Flour Milling Co Nouveaux agents anti-ulcere et compositions pharmaceutiques les contenant
EP0041235B1 (en) * 1980-05-30 1985-02-13 Eisai Co., Ltd. Alpha,beta-dihydropolyprenyl derivatives for treating liver diseases
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
JPS5791932A (en) * 1980-11-28 1982-06-08 Kuraray Co Ltd Polyprenyl compound
JPS57106618A (en) * 1980-12-24 1982-07-02 Eisai Co Ltd Anticancer agent consisting of polyprenyl compound
DE3163920D1 (en) * 1980-12-24 1984-07-05 Eisai Co Ltd Pharmaceutical preparations comprising polyprenyl compounds, especially as anti-cancer agents, and pharmaceutical compositions for the prevention and treatment of cancer and skin diseases
DE3348500C2 (de) * 1982-05-28 1998-10-22 Eisai Co Ltd beta,gamma-Dihydropolyprenylalkoholderivat
DE69325935T2 (de) * 1992-03-17 2000-01-20 Eisai Co Ltd Hautbleichendes Mittel enthaltend Teprenone

Also Published As

Publication number Publication date
GB8508219D0 (en) 1985-05-09
GB2159055A (en) 1985-11-27
GB8508214D0 (en) 1985-05-09
SE8801513L (sv) 1988-04-22
DE3318989A1 (de) 1983-12-01
FR2527597A1 (fr) 1983-12-02
GB2122610B (en) 1987-04-01
DK171640B1 (da) 1997-03-03
US4624966A (en) 1986-11-25
SE502924C2 (sv) 1996-02-19
FR2532843A1 (fr) 1984-03-16
FR2569108A1 (fr) 1986-02-21
ES8406992A1 (es) 1984-09-01
GB2159055B (en) 1987-04-08
DK239483D0 (da) 1983-05-27
FR2569108B1 (fr) 1990-03-02
SE8801515D0 (sv) 1988-04-22
NL194300C (nl) 2001-12-04
DE3348500C2 (de) 1998-10-22
CH654823A5 (fr) 1986-03-14
NL8301892A (nl) 1983-12-16
CA1310660C (en) 1992-11-24
SE502922C2 (sv) 1996-02-19
GB8508217D0 (en) 1985-05-09
ES8507444A1 (es) 1985-09-01
GB2159710B (en) 1987-04-08
IT8321364A1 (it) 1984-11-30
FR2532848B1 (fr) 1986-04-11
NL194300B (nl) 2001-08-01
DE3318989C2 (de) 1996-11-21
AT389871B (de) 1990-02-12
FR2532844B1 (fr) 1986-10-03
US6111131A (en) 2000-08-29
GB2159712B (en) 1987-04-01
ES529754A0 (es) 1985-09-01
FR2532844A1 (fr) 1984-03-16
IT1164256B (it) 1987-04-08
GB2159711A (en) 1985-12-11
SE461650B (sv) 1990-03-12
SE8801513D0 (sv) 1988-04-22
FR2527597B1 (fr) 1989-02-10
US6288128B1 (en) 2001-09-11
ES522789A0 (es) 1984-09-01
SE8801514D0 (sv) 1988-04-22
GB2159710A (en) 1985-12-11
DK239483A (da) 1983-11-29
SE8303013D0 (sv) 1983-05-27
GB8508220D0 (en) 1985-05-09
GB2159712A (en) 1985-12-11
GB8508218D0 (en) 1985-05-09
GB8314419D0 (en) 1983-06-29
GB2159054B (en) 1987-04-08
ES529753A0 (es) 1985-07-16
IT8321364A0 (it) 1983-05-30
SE502923C2 (sv) 1996-02-19
ATA197283A (de) 1989-07-15
GB2159713A (en) 1985-12-11
GB2122610A (en) 1984-01-18
ES8506567A1 (es) 1985-07-16
GB2159054A (en) 1985-11-27
FR2532848A1 (fr) 1984-03-16
SE8303013L (sv) 1983-11-29
SE8801515L (sv) 1988-04-22
GB2159711B (en) 1987-04-01

Similar Documents

Publication Publication Date Title
SE8801515L (sv) Farmaceutisk komposition
MY100343A (en) Amide derivative and external medicament comprising same
FR2416012A1 (fr) Derives de l'imidazole et medicament contenant ces substances
ES485188A1 (es) Procedimiento para preparar 1-piperazina-carboxamidas y car-botiamidas
IL60390A (en) Piperidine derivatives,their preparation and pharmaceutical compositions comprising them
DE3564566D1 (en) Quinone derivatives, method and use of preparing same, and pharmaceutical composition
FR2392971A1 (fr) Derives de l'acide prostanoique, leur preparation et medicament contenant ces substances
ES8404361A1 (es) Un procedimiento para la preparacion de un derivado de cefalosporina.
ES8101530A1 (es) Un procedimiento para la preparacion de alcoholes beta-gama-dihidro-poliprenilicos.
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
ES8205791A1 (es) Procedimiento para la preparacion de derivados de imidazol del sistema de 1,4-benzodioxan-2-ilo
FR2445329A1 (fr) Derives du 11-bromo-14-oxo-15-hydroxy-imino-e-homo-eburnane, leur preparation et leur utilisation comme medicament
JPS5626814A (en) Antibacteria agent and its use
DE3070768D1 (en) 1-((substituted-naphthyl)ethyl)-imidazole derivatives, pharmaceutical compositions containing them and methods of making them
SE8004383L (sv) Farmaceutisk beredning for oral administrering och forfarande for dess framstellning
ES466493A1 (es) Procedimiento de fabricacion de acidos a-aril-a -oxo-isovalericos.
NO166713C (no) Analogifremgangsmaate for fremstikling av terapeutisk aktive monobasiske diisobutamid derivater.
SE8903312D0 (sv) New 2-carbonyl substituted n,n'-di-(trimethoxybenzol)piperazines, process for preparing the same and therapeutical compounds containing them
IT1161210B (it) Metodo per modulare la risposta immunitaria con dibenzocicloeptenilideni
ES479440A1 (es) Un procedimiento para preparar compuestos con propiedades broncodilatadoras.
SE8004351L (sv) (3-alkylamino-2-hydroxipropoxi)-furan-2-karbonsyra-anilider och fysiologiskt fordragbara syraadditionssalter derav samt lekemedel med en halt av dessa foreningar
ATE29133T1 (de) Troponon-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
SE8204791D0 (sv) Process for preparing alkoxy-vincaminic acid esters and alkoxy-apovincaminic acid esters
JPS5427564A (en) 1-branched alkylcarbonyl-3-(3,5-dihalogenophenyl) hydantoins, their preparation, and bactericides for pomicultural and horticultural uses containing the same as active agent.
FR2386540A1 (fr) Derives d'acides furoyl- ou thenoyl- naphtyloxyalkylcarboxyliques, leur preparation et leur utilisation comme medicaments